<DOC>
	<DOCNO>NCT00002008</DOCNO>
	<brief_summary>To determine safety , immunogenicity , biological activity , ad pharmacokinetics sargramostim ( recombinant granulocyte-macrophage colony-stimulating factor ; GM-CSF ) human granulocyte-macrophage colony-stimulating factor ( GM-CSF ) , give subcutaneous ( SC ) injection patient leukopenia association HIV infection .</brief_summary>
	<brief_title>An Open Label Phase I Study Subcutaneously Administered Recombinant Human GM-CSF Patients With AIDS Virus Infection Leukopenia</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Leukopenia</mesh_term>
	<criteria>Inclusion Criteria Patients must : Serum antibody HIV without evidence HIV . Antigenemia . Anticipated survival least 6 month . Allowed : Kaposi 's sarcoma . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Malignancy Kaposi 's sarcoma . Excessive diarrhea ( 5 liquid nonliquid stool per day ) . Currently hospitalize hospitalize within last 4 week treatment opportunistic infection . Primary hematologic infectious disorder unrelated AIDS virus infection . Dementia alter mental status would prohibit give understand informed consent . Patients follow excluded : History malignancy Kaposi 's sarcoma . Currently hospitalize hospitalize within 4 week treatment opportunistic infection . Prior Medication : Excluded within 3 week study entry : Marrow suppressive medication . Excluded within 4 week study entry : Any investigational drug . Prior Treatment : Excluded within 4 week study entry : Systemic cytotoxic chemotherapy . Irradiation . Risk Behavior : Excluded within 3 month study entry : Regular , excessive user alcohol , hallucinogen , agent addict .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 1989</verification_date>
	<keyword>Leukopenia</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Granulocyte-Macrophage Colony-Stimulating Factor</keyword>
</DOC>